Craft

BSBE

Stock Price

¥14

2024-10-29

Market Capitalization

¥8 B

2024-10-29

Revenue

¥1.3 B

FY, 2025

BSBE Summary

Company Summary

Overview
BSBE (Beijing Strong Biotechnologies, 北京九强生物技术股份有限公司) is a company that manufactures clinical chemicals. It focuses on in-vitro diagnostic substances including biochemistry reagent panels, coagulation chemicals, blood grouping cards, biochemistry analyzers, and COVID-19 antigen cards.
Type
Public
Status
Active
Founded
2001
HQ
Beijing, CN | view all locations
Website
https://en.bsbe.com.cn/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Zou Zuojun, Chairman

    • Liang Hongjun, General Manager, Vice Chairman

      • Liu Xi, General Manager, Director

        • Luo Aiping, Director

          LocationsView all

          2 locations detected

          • Beijing, Bei Jing Shi HQ

            China

            5/F Kuang Yi Building, No.15 Hua Yuan Dong Lu, Haidian District

          • Beijing, Bei Jing Shi

            China

            No.15, Yanqi North Second Street, Yanqi Economic Development Area, Huairou District

          BSBE Financials

          Summary Financials

          Revenue (Q1, 2026)
          ¥329.5M
          Gross profit (Q1, 2026)
          ¥269.0M
          Net income (Q1, 2026)
          ¥105.6M
          Cash (Q1, 2026)
          ¥673.3M
          EBIT (Q1, 2026)
          ¥131.2M
          Enterprise value
          $8.4B

          Footer menu